Saliva-based Screening Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global saliva based screening market achieved a revenue of approximately US$ 360 million in 2024, and it is projected to reach a valuation of US$ 670 million by the end of 2031. Saliva-based testing has gained popularity due to its non-invasive nature and simplicity in sample collection, making it an attractive alternative to serum-based testing.

Key Market Insights

Saliva-based screening is becoming increasingly important in the detection of a wide range of diseases, including oral and systemic illnesses. The non-invasive nature of saliva collection, coupled with the presence of numerous disease indicators and biomarkers, has driven the adoption of this technology in diagnostics.

Market Growth Drivers

1. Innovation in Saliva Based Screening: The demand for rapid diagnosis of various diseases is fueling innovation in the field. Manufacturers are developing and introducing innovative solutions to meet the growing demand for quick disease detection, leading to increased competition in the market.

2. Prevalence of Infectious Diseases: The ongoing prevalence of infectious diseases, such as COVID-19, has led to increased approvals of practical and easy-to-use saliva-based test kits. These kits have further driven the demand for saliva-based screening.

3. Availability of Saliva Collection Devices: The increasing availability of saliva collection devices and the preference for non-invasive saliva tests over blood tests for disease diagnosis are contributing to market growth. Technological advancements are also driving product adoption.

Factors Impacting Market Growth

The emergence of new companies introducing testing kits that use nasal swabs and other specimens is limiting the growth of saliva-based screening, despite the advantages of saliva in terms of ease of collection and self-testing.

Booming U.S. Market

The United States is witnessing significant growth in saliva-based screening, driven by the popularity of self-testing and home-based kits. The user-friendliness of self-testing kits and their availability through various distribution channels, including online pharmacies and medicine stores, are contributing to this growth.

Prominent German Market

Germany offers substantial opportunities for manufacturers due to the importance of early disease diagnosis, particularly in managing infections with high mortality rates caused by mutant variations. Rapid test kits have become crucial in early diagnosis, further driving market growth.

Development in India

Initiatives by the Indian government and non-profit organizations are increasing public awareness about the importance of early disease diagnosis. Growing awareness, along with the popularity of self-detection kits for obtaining test results with lower cross-infection risks, is driving market development in India.

Competitive Landscape

Mergers and acquisitions have emerged as a key growth strategy for market participants, with many international corporations investing in research and development to create comprehensive solutions in saliva-based screening kits.

Key Companies Profiled:

Thermo Fisher Scientific
Hologic
Qiagen
Zymo Research Corporation
DNA Genotek Inc.
Invitek Molecular GmbH
Salimetrics, LLC.
BioChain Institute Inc.
Mawi DNA Technologies LLC
Cell Projects Ltd.
Kyodo International, Inc.
Spectrum Solutions
NEOGEN Corporation
Xiamen Zeesan Biotech Co., Ltd.
Sedia Biosciences Corporation
Biosynex SA
Chembio Diagnostics, Inc.
Creative Diagnostics
OraSure Technologies

The global saliva-based screening market is poised for substantial growth due to its non-invasive nature and increasing demand for rapid and practical disease diagnosis.

Market Segmentation

Product:

Saliva collection kits/devices
Saliva nucleic acid purification kits
Saliva base detection kits

PCR based

Rapid kits

Purpose:

Research use only
Diagnostics

Application:

Infection analysis/detection
Genomic analysis
Proteomics
Pharmacogenomics
Liquid biopsy

End User:

Hospitals & Clinics
Diagnostic laboratories
Academic & research institutes
Biopharmaceuticals & CRO's

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

1. Executive Summary

1.1. Global Saliva-based Screening Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Saliva-based Screening Market Outlook, 2018 - 2031

3.1. Global Saliva-based Screening Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Saliva collection kits/devices
  - 3.1.1.2. Saliva nucleic acid purification kits
  - 3.1.1.3. Saliva base detection kits
    - 3.1.1.3.1. PCR based
    - 3.1.1.3.2. Rapid kits
3.2. Global Saliva-based Screening Market Outlook, by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Research use only
  - 3.2.1.2. Diagnostics
3.3. Global Saliva-based Screening Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Infection analysis/detection
  - 3.3.1.2. Genomic analysis
  - 3.3.1.3. Proteomics
  - 3.3.1.4. Pharmacogenomics
  - 3.3.1.5. Liquid biopsy
3.4. Global Saliva-based Screening Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Hospitals & Clinics
  - 3.4.1.2. Diagnostic laboratories
  - 3.4.1.3. Academic & research institutes
  - 3.4.1.4. Biopharmaceuticals & CRO's
3.5. Global Saliva-based Screening Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America Saliva-based Screening Market Outlook, 2018 - 2031

4.1. North America Saliva-based Screening Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Saliva collection kits/devices
  - 4.1.1.2. Saliva nucleic acid purification kits
  - 4.1.1.3. Saliva base detection kits
    - 4.1.1.3.1. PCR based
    - 4.1.1.3.2. Rapid kits
4.2. North America Saliva-based Screening Market Outlook, by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Research use only
  - 4.2.1.2. Diagnostics
4.3. North America Saliva-based Screening Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Infection analysis/detection
  - 4.3.1.2. Genomic analysis
  - 4.3.1.3. Proteomics
  - 4.3.1.4. Pharmacogenomics
  - 4.3.1.5. Liquid biopsy
4.4. North America Saliva-based Screening Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Hospitals & Clinics
  - 4.4.1.2. Diagnostic laboratories
  - 4.4.1.3. Academic & research institutes
  - 4.4.1.4. Biopharmaceuticals & CRO's
4.5. North America Saliva-based Screening Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 4.5.1.2. U.S. Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 4.5.1.3. U.S. Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 4.5.1.4. U.S. Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 4.5.1.5. Canada Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 4.5.1.6. Canada Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 4.5.1.7. Canada Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 4.5.1.8. Canada Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Saliva-based Screening Market Outlook, 2018 - 2031

5.1. Europe Saliva-based Screening Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Saliva collection kits/devices
  - 5.1.1.2. Saliva nucleic acid purification kits
  - 5.1.1.3. Saliva base detection kits
    - 5.1.1.3.1. PCR based
    - 5.1.1.3.2. Rapid kits
5.2. Europe Saliva-based Screening Market Outlook, by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Research use only
  - 5.2.1.2. Diagnostics
5.3. Europe Saliva-based Screening Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Infection analysis/detection
  - 5.3.1.2. Genomic analysis
  - 5.3.1.3. Proteomics
  - 5.3.1.4. Pharmacogenomics
  - 5.3.1.5. Liquid biopsy
5.4. Europe Saliva-based Screening Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Hospitals & Clinics
  - 5.4.1.2. Diagnostic laboratories
  - 5.4.1.3. Academic & research institutes
  - 5.4.1.4. Biopharmaceuticals & CRO's
5.5. Europe Saliva-based Screening Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.2. Germany Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.3. Germany Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.4. Germany Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.5. U.K. Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.6. U.K. Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.7. U.K. Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.8. U.K. Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.9. France Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.10. France Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.11. France Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.12. France Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.13. Italy Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.14. Italy Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.15. Italy Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.16. Italy Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.17. Turkey Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.18. Turkey Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.19. Turkey Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.20. Turkey Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.21. Russia Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.22. Russia Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.23. Russia Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.24. Russia Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.25. Rest of Europe Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.26. Rest of Europe Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.27. Rest of Europe Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 5.5.1.28. Rest of Europe Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Saliva-based Screening Market Outlook, 2018 - 2031

6.1. Asia Pacific Saliva-based Screening Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Saliva collection kits/devices
  - 6.1.1.2. Saliva nucleic acid purification kits
  - 6.1.1.3. Saliva base detection kits
    - 6.1.1.3.1. PCR based
    - 6.1.1.3.2. Rapid kits
6.2. Asia Pacific Saliva-based Screening Market Outlook, by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Research use only
  - 6.2.1.2. Diagnostics
6.3. Asia Pacific Saliva-based Screening Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Infection analysis/detection
  - 6.3.1.2. Genomic analysis
  - 6.3.1.3. Proteomics
  - 6.3.1.4. Pharmacogenomics
  - 6.3.1.5. Liquid biopsy
6.4. Asia Pacific Saliva-based Screening Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Hospitals & Clinics
  - 6.4.1.2. Diagnostic laboratories
  - 6.4.1.3. Academic & research institutes
  - 6.4.1.4. Biopharmaceuticals & CRO's
6.5. Asia Pacific Saliva-based Screening Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. China Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.2. China Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.3. China Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.4. China Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.5. Japan Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.6. Japan Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.7. Japan Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.8. Japan Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.9. South Korea Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.10. South Korea Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.11. South Korea Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.12. South Korea Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.13. India Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.14. India Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.15. India Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.16. India Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.17. Southeast Asia Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.18. Southeast Asia Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.19. Southeast Asia Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.20. Southeast Asia Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.21. Rest of Asia Pacific Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.22. Rest of Asia Pacific Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.23. Rest of Asia Pacific Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.5.1.24. Rest of Asia Pacific Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Saliva-based Screening Market Outlook, 2018 - 2031

7.1. Latin America Saliva-based Screening Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Saliva collection kits/devices
  - 7.1.1.2. Saliva nucleic acid purification kits
  - 7.1.1.3. Saliva base detection kits
    - 7.1.1.3.1. PCR based
    - 7.1.1.3.2. Rapid kits
7.2. Latin America Saliva-based Screening Market Outlook, by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.3. Latin America Saliva-based Screening Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Infection analysis/detection
  - 7.3.1.2. Genomic analysis
  - 7.3.1.3. Proteomics
  - 7.3.1.4. Pharmacogenomics
  - 7.3.1.5. Liquid biopsy
7.4. Latin America Saliva-based Screening Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Hospitals & Clinics
  - 7.4.1.2. Diagnostic laboratories
  - 7.4.1.3. Academic & research institutes
  - 7.4.1.4. Biopharmaceuticals & CRO's
7.5. Latin America Saliva-based Screening Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.5.1.2. Brazil Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.5.1.3. Brazil Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.5.1.4. Brazil Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.5.1.5. Mexico Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.5.1.6. Mexico Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.5.1.7. Mexico Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.5.1.8. Mexico Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.5.1.9. Argentina Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.5.1.10. Argentina Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.5.1.11. Argentina Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.5.1.12. Argentina Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.5.1.13. Rest of Latin America Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.5.1.14. Rest of Latin America Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.5.1.15. Rest of Latin America Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.5.1.16. Rest of Latin America Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Saliva-based Screening Market Outlook, 2018 - 2031

8.1. Middle East & Africa Saliva-based Screening Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Saliva collection kits/devices
  - 8.1.1.2. Saliva nucleic acid purification kits
  - 8.1.1.3. Saliva base detection kits
    - 8.1.1.3.1. PCR based
    - 8.1.1.3.2. Rapid kits
8.2. Middle East & Africa Saliva-based Screening Market Outlook, by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Research use only
  - 8.2.1.2. Diagnostics
8.3. Middle East & Africa Saliva-based Screening Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Infection analysis/detection
  - 8.3.1.2. Genomic analysis
  - 8.3.1.3. Proteomics
  - 8.3.1.4. Pharmacogenomics
  - 8.3.1.5. Liquid biopsy
8.4. Middle East & Africa Saliva-based Screening Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Hospitals & Clinics
  - 8.4.1.2. Diagnostic laboratories
  - 8.4.1.3. Academic & research institutes
  - 8.4.1.4. Biopharmaceuticals & CRO's
8.5. Middle East & Africa Saliva-based Screening Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.2. GCC Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.3. GCC Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.4. GCC Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.5. South Africa Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.6. South Africa Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.7. South Africa Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.8. South Africa Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.9. Egypt Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.10. Egypt Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.11. Egypt Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.12. Egypt Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.13. Nigeria Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.14. Nigeria Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.15. Nigeria Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.16. Nigeria Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.17. Rest of Middle East & Africa Saliva-based Screening Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.18. Rest of Middle East & Africa Saliva-based Screening Market by Purpose, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.19. Rest of Middle East & Africa Saliva-based Screening Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.5.1.20. Rest of Middle East & Africa Saliva-based Screening Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. by Application vs by Purpose Heatmap
9.2. Manufacturer vs by Purpose Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Thermo Fisher Scientific
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Hologic
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Qiagen
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Zymo Research Corporation
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. DNA Genotek Inc.
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. Invitek Molecular GmbH
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Salimetrics, LLC.
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. BioChain Institute Inc.
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. Mawi DNA Technologies LLC
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development
- 9.5.10. Cell Projects Ltd.
  - 9.5.10.1. Company Overview
  - 9.5.10.2. Product Portfolio
  - 9.5.10.3. Financial Overview
  - 9.5.10.4. Business Strategies and Development
- 9.5.11. Kyodo International, Inc.
  - 9.5.11.1. Company Overview
  - 9.5.11.2. Product Portfolio
  - 9.5.11.3. Financial Overview
  - 9.5.11.4. Business Strategies and Development
- 9.5.12. Spectrum Solutions
  - 9.5.12.1. Company Overview
  - 9.5.12.2. Product Portfolio
  - 9.5.12.3. Financial Overview
  - 9.5.12.4. Business Strategies and Development
- 9.5.13. NEOGEN Corporation
  - 9.5.13.1. Company Overview
  - 9.5.13.2. Product Portfolio
  - 9.5.13.3. Financial Overview
  - 9.5.13.4. Business Strategies and Development
- 9.5.14. Xiamen Zeesan Biotech Co., Ltd.
  - 9.5.14.1. Company Overview
  - 9.5.14.2. Product Portfolio
  - 9.5.14.3. Financial Overview
  - 9.5.14.4. Business Strategies and Development
- 9.5.15. Sedia Biosciences Corporation
  - 9.5.15.1. Company Overview
  - 9.5.15.2. Product Portfolio
  - 9.5.15.3. Financial Overview
  - 9.5.15.4. Business Strategies and Development
- 9.5.16. Biosynex SA
  - 9.5.16.1. Company Overview
  - 9.5.16.2. Product Portfolio
  - 9.5.16.3. Financial Overview
  - 9.5.16.4. Business Strategies and Development
- 9.5.17. Chembio Diagnostics, Inc.
  - 9.5.17.1. Company Overview
  - 9.5.17.2. Product Portfolio
  - 9.5.17.3. Financial Overview
  - 9.5.17.4. Business Strategies and Development
- 9.5.18. Creative Diagnostics
  - 9.5.18.1. Company Overview
  - 9.5.18.2. Product Portfolio
  - 9.5.18.3. Financial Overview
  - 9.5.18.4. Business Strategies and Development
- 9.5.19. OraSure Technologies
  - 9.5.19.1. Company Overview
  - 9.5.19.2. Product Portfolio
  - 9.5.19.3. Financial Overview
  - 9.5.19.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations